ONE
ONEVIEW CDI 1:1 [ONE]
Healthcare · ASX Small Cap
$0.1900 -2.6%
Updated 26 Mar 2026 · Scores refresh every scan
Score Breakdown
Technical52
Catalyst53
Sentiment50
Fundamental75
Momentum49
Risk Gate40
Get alerts when ONE's score changes
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- RSI drifting toward oversold territory — worth watching
- Stochastic is deep in oversold territory — bounce conditions forming
- Above-average volume (1.6x) on a red day — sellers in control
- Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
- Sitting near support — this level has held before and could attract buyers again
- Lagging the Small Ords index — relative strength of 0.79, underperforming its peers
- Volatility is contracting — like a spring being compressed, breakouts often follow
- Low cash runway (2 quarters) - dilution risk
- Moderate P/S ratio (14.2x)
- Moderate revenue growth (+8%)
- EPS estimates revised upward (+10pts)
- Near 52-week low (12% of range)
- CANSLIM S: Tight float (40%)
- CANSLIM I: Institutional ownership (15%)
- Sentiment is mixed — no strong consensus either way
- Days to cover very high (40.8)
- RBA hiking (-3pts)
Risk Signals
- Trading below both moving averages — the trend is working against this one
- Below the 200-day average — the long-term trend is still working against it
- Deeply negative margins (-105%)
- Not enough chatter to gauge sentiment — defaulting to neutral
- The bigger volume days are the down days — volume-weighted momentum is negative (-0.61%/day)
- Overseas neutral (-2pts, S&P500 neutral, VIX 25)
Ask Scout AI about ONE
3 free messages/day · Unlimited with Pro
Recent Catalysts
NONE Appendix 4G
NONE Corporate Governance Statement
NONE Security Purchase Plan
LOW Annual Report to shareholders
Recent ASX Announcements
| 2026-03-25 | Appendix 4G |
| 2026-03-25 | Corporate Governance Statement |
| 2026-03-25 | Annual Report to shareholders |
| 2026-03-24 | Security Purchase Plan PRICE SENSITIVE |
| 2026-03-24 | Cleansing Statement |
Key Metrics
$170.1M
Market Cap
275K
Avg Volume
1.6x
Vol Ratio
$0.17 — $0.41
52-Week Range
1.5%
Short Interest
N/A
Cash Runway
-149.0%
ROE
-104.9%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | pass | Float: 40% |
| L | Leader vs Laggard | laggard | RS: -12 |
| I | Institutional Sponsorship | pass | Inst: 15% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
Ranked #67 of 117 · Sector avg: 46
View all Healthcare signals →Track ONE and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and conviction scoring for every ASX small cap.
No credit card required